Home » Topics » BioWorld Science

BioWorld Science
RSS

Catalyst announces pivotal phase III design for MarzAA

April 8, 2020

CellCentric enters agreement with PCCTC for phase II dose-expansion study of CCS-1477

April 8, 2020

FDA approves the initiation of stem cell study for protection against COVID-19

April 8, 2020

Phase IIa study of golexanolone shows no clinical benefit

April 8, 2020

Stopping tau in its tracks

April 8, 2020

Minimal phenotyping gives minimal insights into MDD genetics

April 8, 2020

Aviptadil enters clinical trials to treat COVID-19-related ARDS

April 7, 2020

Crinetics reports interim data from phase II ACROBAT EDGE trial of paltusotine in acromegaly

April 7, 2020

PKX-001 demonstrates safety and efficacy in dry eye disease model

April 7, 2020

SARS-CoV-2 vaccine shows promise in first peer-reviewed article on a potential COVID-19 vaccine

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...